Saudi Arabia vs Sweden: Access to anti-retroviral drugs, male
Saudi Arabia
93.0%
in 2024
Sweden
95.0%
in 2022
Saudi Arabia rank
7th
Sweden rank
4th
Access to anti-retroviral drugs, male over time
- Saudi Arabia
- Sweden
How they compare
Sweden currently reports 95.0% against 93.0% in Saudi Arabia, a difference of 2.0%.
Across all 23 years both countries report, Sweden has been ahead every year.
Saudi Arabia ranks 7th and Sweden ranks 4th of 141 countries.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 27.0% | 53.7% | 26.7% | Sweden |
| 2010s | 56.4% | 92.5% | 36.1% | Sweden |
| 2020s | 90.7% | 95.3% | 4.7% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Saudi Arabia or Sweden?
- Sweden, at 95.0% against 93.0% in Saudi Arabia as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Saudi Arabia and Sweden?
- 2.0%, with Sweden ahead.
- How many years of comparable data are there for Saudi Arabia and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Saudi Arabia and Sweden rank globally for access to anti-retroviral drugs, male?
- Saudi Arabia ranks 7th and Sweden ranks 4th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.